Maximizing Pharmaceutical Patent Life Cycles: Strategies to Avoid Obviousness Findings - Legal Analysis and Practical Applications
WTO and Its Effect on Indian Pharmaceutical Companies
Evolution Of IPR
Intellectual Property Provisions of the TPP Proposals and Dangers for Access to Medicines
Patents by dps parmar [compatibility mode]
1 DANGER AND USE OF PROVISIONAL APPLICATIONS Maria Eliseeva HOUSTON ELISEEVA LLP Boston, MA June 9, 2005, San Francisco June 16, 2005, Chicago AIPLA ADVANCED.
TECHNOLOGY LICENSING TODAY (Highlights of Technology Licensing Course) Karl F. Jorda David Rines Professor of Intellectual Property Law & Industrial Innovation.
WHO/UNICEF Technical Briefing Seminar on Essential Medicines Policies (19-23 September 2005) TRADE, TRIPS AND ACCESS TO MEDICINES Cecilia Oh Department.
Using patent information for policy and business analysis William Meredith Head, Global IP Information Service WIPO.
Ariad v. Eli Lilly 560 F.3d 1366 (Fed. Cir. 2009) Written Description as a Function of Enablement N. Scott Pierce, Esq. Suffolk University Law School November.
1 United States Patents An Overview. 2 VIDEO Should this guy look into getting a patent?? (click here)
Pharmaceuticals